BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2016

May 25, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2016-05-23

Reporting Person: Hutson Nancy J (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-23	Automatic Stock Option Grant	$3.22	A	30000	Acquired	2026-05-23	Common Stock (30000)	Direct

Footnotes

F1: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan.

F2: Vests 1/12th per month over twelve months beginning June 23, 2016.